BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ENV-294 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ENV-294\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07301255-1361@assetmemo.bio
DTSTAMP:20261121T004532Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ENV-294: Phase 2 readout est. (NCT07301255)
DESCRIPTION:ENV-294\, phase 2\, Asthma.\nStudy: ENV-294 for Moderate-to-Sev
 ere Asthma: A 12-Week Study in Adults\nEstimated primary completion: Decem
 ber 2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/env-294#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0730125
 5
URL:https://assetmemo.bio/drug/env-294#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07298395-1361@assetmemo.bio
DTSTAMP:20261121T004532Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ENV-294: Phase 2 readout est. (NCT07298395)
DESCRIPTION:ENV-294\, phase 2\, Atopic Dermatitis.\nStudy: Study of ENV-294
  in Adults With Moderate-to-Severe Atopic Dermatitis\nEstimated primary co
 mpletion: December 2026. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/env-294#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07298395
URL:https://assetmemo.bio/drug/env-294#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07643766-1361@assetmemo.bio
DTSTAMP:20261121T004532Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:ENV-294: Phase 2 readout est. (NCT07643766)
DESCRIPTION:ENV-294\, phase 2\, Atopic Dermatitis.\nStudy: A Phase 2b Dose-
 Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults Wit
 h Moderate-to-Severe Atopic Dermatitis\nEstimated primary completion: Dece
 mber 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/env-294#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT076437
 66
URL:https://assetmemo.bio/drug/env-294#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
